Traditional, Alternative & Non-Dilutive Financing
In partnership with
Sponsored by
Every year, more sources of capital for bioscience commercialization and company growth establish operations in Ohio. Likewise, the pipeline of Ohio biomedical startup and spinout companies continues to flow. Today BioOhio and the Ohio Capital Fund are providing a venue for investors and growing company leaders to share ideas, interact and network.
March 5th, 2014 1:30pm – 6:00pm
TechColumbus, 1275 Kinnear Road, Columbus, OH 43212 (map)
Sources of Capital/Funders may attend at no charge.
Master of Ceremonies and Moderator – John F. Lewis Jr., President and CEO, BioOhio
1:30 – Investors Panel
- Peter Kleinhenz, Managing Director, CID Capital; Venture Partner, Fletcher Spaght Ventures
- John Huston, Founder, Ohio TechAngels
- Paul Cohn, Partner, Fort Washington Capital Partners
- Q&A
2:15 – Alternative Sources of Funding
- Therapeutic/Disease Foundations: Tim Miller, Abeona Therapeutics
- Ohio Third Frontier and EB5: Brian Hicks, Hicks Partners
- Strategic Corporate Investor: Joshua Gaines, SVP, Strategy & Corporate Development, Cardinal Health
- Healthcare Fund Management: Matthew Wotiz, Principal at OrbiMed Advisors
- Venture Banking: John Hoesley, Managing Director, Silicon Valley Bank
- Q&A
3:30 – Entrepreneurial Words of Wisdom
- Jon Snyder, President & CEO, Neuros Medical
- Kevin Mendelsohn, Vice President, Finance & Corporate Development, CardioInsight Technologies
- Joseph Gardner, CEO, Aerpio Therapeutics
- Q&A
4:30 – 6:00 Networking Reception